RVL Pharmaceuticals (FRA:O1P) Short-Term Capital Lease Obligation : €0.19 Mil (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is RVL Pharmaceuticals Short-Term Capital Lease Obligation?

RVL Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was €0.19 Mil.

RVL Pharmaceuticals's quarterly Short-Term Capital Lease Obligation declined from Dec. 2022 (€0.42 Mil) to Mar. 2023 (€0.30 Mil) and declined from Mar. 2023 (€0.30 Mil) to Jun. 2023 (€0.19 Mil).

RVL Pharmaceuticals's annual Short-Term Capital Lease Obligation declined from Dec. 2020 (€1.00 Mil) to Dec. 2021 (€0.75 Mil) and declined from Dec. 2021 (€0.75 Mil) to Dec. 2022 (€0.42 Mil).

RVL Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for RVL Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RVL Pharmaceuticals Short-Term Capital Lease Obligation Chart

RVL Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.11

1.97

1.00

0.75

0.42

RVL Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.52	0.53	0.42	0.30	0.19

RVL Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

RVL Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of RVL Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

RVL Pharmaceuticals (FRA:O1P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RVL Pharmaceuticals PLC (FRA:O1P) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

RVLPQ:USA

Address

400 Crossing Boulevard, Bridgewater, NJ, USA, 08807

Website

https://www.rvlpharma.com

RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.

RVL Pharmaceuticals (FRA:O1P) Headlines

No Headlines